Stanton Marshall S. 4
4 · ARTIVION, INC. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Artivion (AORT) SVP Stanton S. Marshall Sells 1,513 Shares
What Happened
- Stanton S. Marshall, SVP, Clinical & Medical Affairs at Artivion, sold 1,513 shares on 2026-03-02 at $38.02 per share, generating proceeds of about $57,532. The Form 4 shows this was a sell-to-cover tied to restricted stock unit vesting to satisfy tax withholding — not a discretionary open-market trade.
Key Details
- Transaction date and price: 2026-03-02 — 1,513 shares sold at $38.02 each.
- Total proceeds: approximately $57,532.
- Reason/footnote: Sale executed to cover tax withholding on RSU vesting (sell-to-cover); transaction not discretionary.
- Transaction code: S (sale); footnote type: F (tax withholding).
- Filing date: 2026-03-03 — appears to be filed promptly (timely).
- Shares owned after transaction: not specified in the provided excerpt of the filing (see full Form 4 for current holdings).
Context
- This was a routine sell-to-cover to pay taxes when restricted stock units vested, which is common and does not necessarily signal insider sentiment about the company. Retail investors should focus more on discretionary purchases by insiders when evaluating signals of confidence. For exact post-transaction holdings or related grants, review the full Form 4 filing.
Insider Transaction Report
Form 4
ARTIVION, INC.AORT
Stanton Marshall S.
SVP, Clinical & MD Affair
Transactions
- Sale
Common Stock
[F1]2026-03-02$38.02/sh−1,513$57,532→ 40,408 total
Footnotes (1)
- [F1]These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
Signature
/s/ Marshall Stanton|2026-03-03